[Expression and clinical significances of c-myb and Bax proteins in endometrial carcinoma]
Related Experiment Video
Updated: Apr 21, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Objective:
To study the expressions of c-myb and Bax proteins and their relationships with clinic-pathological characteristics in endometrial carcinoma.
Methods:
The expressions of c-myb and Bax protein were detected by immunohistochemistry in 42 normal endometrial tissues and 68 endometrial carcinoma tissues. Apoptosis index was detected by TUNEL technique.
Results:
The positive expression rates of c-myb and Bax in endometrial carcinoma were significantly higher than those in normal endometrial tissues (P < 0.05). The expressions of c-myb and Bax in low differentiated endometrial carcinoma were higher than those in high and middle differentiated endometrial carcinoma (P < 0.05). The expressions of c-myb and Bax in stage III and stage IV endometrial carcinoma were higher than those in stage I and stge II endometrial carcinoma (P < 0.05). Apoptosis index in endometrial carcinoma was higher than that in normal endometrial carcinoma. The poorer the cellular differentiation was, the higher the apoptosis index was. There was positive correlation between the expression of Bax and apoptosis index (P < 0.05), but no correlation between the expression of c-myb and apoptosis index (P > 0.05).
Conclusion:
Endometrial carcinoma has high expression of c-myb and Bax, and the expression status of both c-myb and Bax may be related to the malignant degree and prognosis of endometrial carcinoma.
Related Concept Videos
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic...
Abnormal Proliferation
The Intrinsic Apoptotic Pathway
Mitogens and the Cell Cycle

